These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 24304374)
1. The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers. George B; Mathews V; Lakshmi KM; Melinkeri S; Sharma A; Viswabandya A; Sharma S; Das S; Ahmed R; Abraham A; Nair V; Apte S; Chandy M; Srivastava A Clin Transplant; 2013; 27(6):923-9. PubMed ID: 24304374 [TBL] [Abstract][Full Text] [Related]
2. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183 [TBL] [Abstract][Full Text] [Related]
3. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079 [TBL] [Abstract][Full Text] [Related]
4. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia]. Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488 [TBL] [Abstract][Full Text] [Related]
5. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan. Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274 [TBL] [Abstract][Full Text] [Related]
6. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience. Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614 [TBL] [Abstract][Full Text] [Related]
7. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS; Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278 [TBL] [Abstract][Full Text] [Related]
9. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies. Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660 [TBL] [Abstract][Full Text] [Related]
10. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen. Wang SB; Li L; Pan XH; Hu DM; Peng LH; Liu L; Xie ZJ; Yin B; Sun XJ; Yu J; Liang Y Clin Transplant; 2013; 27(2):E109-15. PubMed ID: 23387380 [TBL] [Abstract][Full Text] [Related]
11. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bacigalupo A; Locatelli F; Lanino E; Marsh J; Socié G; Maury S; Prete A; Locasciulli A; Cesaro S; Passweg J; Bone Marrow Transplant; 2005 Dec; 36(11):947-50. PubMed ID: 16205733 [TBL] [Abstract][Full Text] [Related]
12. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood. Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451 [TBL] [Abstract][Full Text] [Related]
13. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255 [TBL] [Abstract][Full Text] [Related]
14. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427 [TBL] [Abstract][Full Text] [Related]
15. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Ghanem KM; Kharfan-Dabaja MA; El-Solh H; Harris N; Kreidieh N; Nehme R; Muwakkit SA; Saab R; Bazarbachi A; Abboud MR Curr Res Transl Med; 2017 Sep; 65(3):115-119. PubMed ID: 28988743 [TBL] [Abstract][Full Text] [Related]
16. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients. Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460 [TBL] [Abstract][Full Text] [Related]
18. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661 [TBL] [Abstract][Full Text] [Related]
19. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India. Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007 [TBL] [Abstract][Full Text] [Related]